Tag: #Global Trends

U.S. pharmaceutical giant Pfizer has agreed to divest its entire interest in ViiV Healthcare, a global specialist in HIV treatment,... Read more

The French biotech firm Valneva has announced the permanent withdrawal of its chikungunya vaccine, Ixchiq, from the United States. This... Read more

Pharmaceutical giant Takeda is implementing a new round of job cuts in the United States as it prepares for the... Read more

Pharmaceutical giant GSK is undertaking a strategic move to optimize the administration of its flagship immunotherapy through a new technological... Read more

Recognition from U.S. regulatory authorities On January 19, 2026, the U.S. Food and Drug Administration (FDA) officially granted "Breakthrough Therapy"... Read more

Signals of a capital market recovery The beginning of 2026 has witnessed signs of a resurgence in the biotech IPO... Read more

Consolidation of global control On January 19, 2026, AstraZeneca officially reached an agreement to acquire AbelZeta Pharma’s 50% stake in... Read more

Executive leadership transition On January 16, 2026, Emmecell, a clinical-stage biotechnology company pioneering magnetic cell delivery (MCD) technology, officially appointed... Read more

Extension of strategic partnership Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has officially extended its long-standing... Read more